NCT00771888View on ClinicalTrials.gov

Open-Label Extension of LOCKCYST Trial

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

August 31, 2009

Conditions
Polycystic Liver DiseaseHepatomegalyLiver DiseasesPolycystic KidneyAutosomal Dominant
Interventions
DRUG

lanreotide

lanreotide

Trial Locations (2)

Unknown

University Hospital Gasthuisberg, University of Leuven, Leuven

6500 HB

Radboud University Nijmegen Medical Center, Nijmegen

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Radboud University Medical Center

OTHER